- FTC Approves Final Orders In PaymentsMD Privacy Case ( )
- FTC Puts Conditions on Sun Pharmaceutical’s Proposed Acquisition of Ranbaxy ( )
- FTC Approves Final Order Preserving Future Competition in the Market for Drug-coated Balloon Catheters Used to Treat Peripheral Artery Disease ( )
- FTC Requests Public Comments on Application from Owners of Surgery Center Holdings, Inc. for Approval to Divest Assets in Central Florida ( )
- FTC Staff Urges Dental Accreditation Commission To Adopt Dental Therapy Accreditation Standards ( )
- FTC Puts Conditions on Medtronic’s Proposed Acquisition of Covidien ( )
- FTC Requires Divestiture as a Condition of Surgery Center Holdings' Acquisition of Competitor Symbion ( )
- FTC Settlement Bans Bogus Trade Association from Selling Healthcare-Related Products ( )
- FTC Staff Comment: Proposed Dental Services Rules in Texas Would Likely Reduce the Benefits of Competition for Consumers ( )
- FTC Halts Fake Medicare Scheme that Took Money from Seniors’ Bank Accounts ( )
- FTC Stops Marketers of Phony Health Care ‘Discount’ Schemes Directed at Older Americans and Spanish-Speaking Consumers ( )
- La FTC frena las operaciones de comercializadores de falsos esquemas de ‘descuentos’ para la atención de la salud dirigidos contra estadounidenses de edad avanzada y consumidores hispanohablantes ( )
- FTC Sues Pharmaceutical Companies for Illegally Blocking Consumer Access to Lower-Cost Versions of the Blockbuster Drug AndroGel ( )
- FTC Approves Final Order in Case Against GMR Transcription Services ( )
- Cactus Juice Marketers to Pay $3.5 Million in Refunds to Consumers for Deceptive Claims that Their Product Treats Diseases ( )
- L’Oréal Settles FTC Charges Alleging Deceptive Advertising for Anti-Aging Cosmetics ( )
- La FTC testifica ante el Subcomité de Comercio del Senado sobre los esfuerzos de la agencia para combatir las declaraciones fraudulentas y engañosas sobre productos para perder peso ( )
- FTC Testifies Before Senate Commerce Subcommittee on Agency Efforts to Combat Fraudulent and Deceptive Claims for Weight-Loss Products ( )
- Supplement Marketers Settle FTC Charges that “BrainStrong Adult” Memory Improvement Claims Are Deceptive ( )
- Company Settles FTC Charges that Head Lice Prevention Claims Were Deceptive ( )
- FTC Charges Green Coffee Bean Sellers with Deceiving Consumers through Fake News Sites and Bogus Weight Loss Claims ( )
- FTC Approves Final Consent Orders Settling Charges that Companies Deceptively Claimed Their Genetically Modified Nutritional Supplements Could Treat Diseases ( )
- FTC Staff: Missouri Should Consider Changing Physician Supervision Requirements for Advanced Practice Registered Nurses ( )
- FTC Announces Agenda, Panelists for Upcoming Seminar on Privacy Implications of Consumer Generated and Controlled Health Data ( )
- FTC Approves Final Order Settling Charges That Community Health Systems, Inc.’s Acquisition of Health Management Associates Inc. was Anticompetitive in Two Local Markets ( )
- FTC Puts Conditions on Akorn Enterprises’ Proposed Purchase of Hi-Tech Pharmacal ( )
- FTC Approves Final Consent Settling Charges that L’Occitane, Inc. Misled Consumers to Believe that Creams Could Slim Their Bodies ( )
- FTC Chairwoman Releases 2013 Annual Highlights ( )
- FTC Announces Agenda for March 20-21 Workshop Examining U.S. Health Care Competition Issues ( )
- FTC Staff Opinion: Rx Program Operated for the Benefit of Non-Profit Schools, Colleges, and Universities Appears to Fall within the NPIA Exemption to Robinson-Patman ( )